GlycoMimetics (GLYC) Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals Jun 5, 2025 04:01PM
Cantor Fitzgerald Reiterates Overweight Rating on Glycomimetics (GLYC) Mar 21, 2025 06:39AM
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of GlycoMimetics, Inc. (GLYC) Mar 3, 2025 05:15PM
GlycoMimetics (GLYC) Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint Oct 29, 2024 07:10AM
GlycoMimetics (GLYC) Enters Acquisition Agreement With Crescent Biopharma Oct 29, 2024 07:02AM


Jul 26, 2024 05:29AM TD Cowen Downgrades Glycomimetics (GLYC) to Hold
Jul 25, 2024 09:02AM GlycoMimetics (GLYC) Announces Strategic Review and Corporate Restructuring Plan